• Explore /
  • Poster
  • / Phase I adult brain tumor consortium (ABTC) trial of ABT-888 (veliparib), temozolomide (TMZ), and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM) including pharmacokinetic (PK) data.

Phase I adult brain tumor consortium (ABTC) trial of ABT-888 (veliparib), temozolomide (TMZ), and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM) including pharmacokinetic (PK) data.

Abstract Poster

Authors

null

Lawrence Kleinberg

The Johns Hopkins University, Baltimore, MD

Lawrence Kleinberg , Jeffrey G. Supko , Tom Mikkelsen , Jaishri O'Neill Blakeley , Glen Stevens , Xiaobu Ye , Serena Desideri , Samuel Ryu , Bhardwaj Desai , Vincent L. Giranda , Stuart A. Grossman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT00770471

Citation

J Clin Oncol 31, 2013 (suppl; abstr 2065)

DOI

10.1200/jco.2013.31.15_suppl.2065

Abstract #

2065

Poster Bd #

4E

Abstract Disclosures

Similar Posters

First Author: Anthony J. Chalmers

First Author: Jack M. Su

First Author: Dinu Stefan

First Author: Jiayi Huang